Alliance Pharma PLC (STU:DVL)
€ 0.54 -0.005 (-0.92%) Market Cap: 304.18 Mil Enterprise Value: 408.65 Mil PE Ratio: 0 PB Ratio: 1.14 GF Score: 74/100

Full Year 2022 Alliance Pharma PLC Earnings Call Transcript

Mar 21, 2023 / 10:00AM GMT
Release Date Price: €0.66 (-0.75%)
Andrew Timothy Franklin
Alliance Pharma plc - Interim CEO, CFO & Executive Director

So good morning and a very warm welcome to our 2022 results presentation. Today, I'm very pleased to be joined by Jeyan Heper. Jeyan joined Alliance last month as Chief Operating Officer. And in such a short time, he's gained a very good understanding of our business and is putting his 25 years' experience gained in international health care companies to good use. I'm also very pleased to let you know that Pete Butterfield has commenced his return-to-work. And Pete will initially focus on preparing for the upcoming Competition Appeals Tribunal in June, and then I'll hand back the CEO responsibilities to Pete.

So today, Jeyan and I will cover last year's performance, an update to our purpose, vision and strategy and conclude with some outlook and summary remarks for this year. So we recognize that last year didn't deliver the trading performance that we had expected. And this was due to 2 discrete areas in our business. Sales of Kelo-cote were impacted in China due to COVID-related lockdowns of destocking at a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot